• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化性血脂异常共识建议在基层医疗环境中的应用。DAT-AP研究。

The application of atherogenic dyslipidaemia consensus recommendations in the primary care setting. DAT-AP study.

作者信息

Rodríguez Angel Díaz, Cumplido Adalberto Serrano, Nuñez-Cortés Jesús Millán, Rodríguez de Miguel Marta, Orera-Peña Mª Luisa

机构信息

Primary Care Center, Bembibre, León, Spain.

Primary Care Center, Bizkaia, Spain.

出版信息

Clin Investig Arterioscler. 2017 Jul-Aug;29(4):178-184. doi: 10.1016/j.arteri.2017.04.003. Epub 2017 Jun 23.

DOI:10.1016/j.arteri.2017.04.003
PMID:28648670
Abstract

BACKGROUND AND AIMS

The "DAT-AP" (from the Spanish, "Dislipemia ATerogénica en Atención Primaria", for Atherogenic Dyslipidaemia in Primary Care) study objective is to determine to what extent published consensus guidelines for the diagnostic and therapeutic management of AD are used in the primary care setting, and to evaluate the approach of the participating physicians towards the detection, diagnosis, and treatment of AD.

METHODS

This is descriptive, cross-sectional, multicentre study performed between January and May 2015 in primary care centres throughout Spain. Study data were collected in 2 independent blocks, the first addressing theoretical aspects of AD and the second, practical aspects (clinical cases) RESULTS: The theoretical part is in the process of publication. This manuscript depicts the clinical cases block. Although study participants showed good knowledge of the subject, the high prevalence of this disease requires an additional effort to optimise detection and treatment, with the implementation of appropriate lifestyle interventions and the prescription of the best treatment.

摘要

背景与目的

“DAT-AP”(源自西班牙语“Dislipemia ATerogénica en Atención Primaria”,意为初级保健中的致动脉粥样硬化性血脂异常)研究的目的是确定在初级保健环境中,已发表的关于动脉粥样硬化性血脂异常(AD)诊断和治疗管理的共识指南的使用程度,并评估参与研究的医生对AD的检测、诊断和治疗方法。

方法

这是一项描述性、横断面、多中心研究,于2015年1月至5月在西班牙各地的初级保健中心进行。研究数据收集于2个独立部分,第一部分涉及AD的理论方面,第二部分涉及实践方面(临床病例)。结果:理论部分正在发表过程中。本手稿描述了临床病例部分。尽管研究参与者对该主题有较好的了解,但这种疾病的高患病率需要额外努力以优化检测和治疗,实施适当的生活方式干预并开具最佳治疗处方。

相似文献

1
The application of atherogenic dyslipidaemia consensus recommendations in the primary care setting. DAT-AP study.动脉粥样硬化性血脂异常共识建议在基层医疗环境中的应用。DAT-AP研究。
Clin Investig Arterioscler. 2017 Jul-Aug;29(4):178-184. doi: 10.1016/j.arteri.2017.04.003. Epub 2017 Jun 23.
2
Management of atherogenic dyslipidemia in the primary care setting in Spain.西班牙基层医疗环境中动脉粥样硬化性血脂异常的管理。
Clin Investig Arterioscler. 2019 Sep-Oct;31(5):203-209. doi: 10.1016/j.arteri.2019.03.001. Epub 2019 Jul 15.
3
[The role of atherogenic dyslipidaemia in clinical practice guidelines].[致动脉粥样硬化性血脂异常在临床实践指南中的作用]
Clin Investig Arterioscler. 2016 Mar-Apr;28(2):65-70. doi: 10.1016/j.arteri.2015.12.004. Epub 2016 Mar 2.
4
Practical recommendations for the management of cardiovascular risk associated with atherogenic dyslipidemia, with special attention to residual risk. Spanish adaptation of a European Consensus of Experts.关于动脉粥样硬化性血脂异常相关心血管风险管理的实用建议,特别关注残余风险。欧洲专家共识的西班牙语改编版
Clin Investig Arterioscler. 2017 Jul-Aug;29(4):168-177. doi: 10.1016/j.arteri.2016.12.001. Epub 2017 Apr 19.
5
[Atherogenic dyslipidemia: a multidisciplinary consensus panel].[致动脉粥样硬化性血脂异常:多学科共识小组]
Clin Investig Arterioscler. 2013 Apr-Jun;25(2):83-91. doi: 10.1016/j.arteri.2013.03.001. Epub 2013 Jun 6.
6
[Map of resources and healthcare needs for patients with dyslipidaemia in Spain: The MADI study].[西班牙血脂异常患者的资源与医疗需求地图:MADI研究]
Clin Investig Arterioscler. 2016 Nov-Dec;28(6):257-264. doi: 10.1016/j.arteri.2016.06.005. Epub 2016 Sep 28.
7
[Diagnosis of atherogenic dyslipidaemia by primary care physicians in Spain].
Semergen. 2021 Mar;47(2):99-105. doi: 10.1016/j.semerg.2020.07.008. Epub 2020 Oct 29.
8
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.西班牙动脉硬化协会关于致动脉粥样硬化性血脂异常管理的共识文件。
Clin Investig Arterioscler. 2017 Mar-Apr;29(2):86-91. doi: 10.1016/j.arteri.2016.11.001. Epub 2017 Feb 6.
9
[Patient's care and management of dyslipidemia in type 2 diabetic patients in the clinical practice in Spain: The LIPEDIA study].[西班牙临床实践中2型糖尿病患者血脂异常的患者护理与管理:LIPEDIA研究]
Clin Investig Arterioscler. 2015 Mar-Apr;27(2):45-56. doi: 10.1016/j.arteri.2014.06.002. Epub 2014 Aug 10.
10
Use of expert consensus to improve atherogenic dyslipidemia management.利用专家共识改善致动脉粥样硬化性血脂异常管理。
Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):36-44. doi: 10.1016/j.rec.2013.06.011. Epub 2013 Nov 8.

引用本文的文献

1
Oral Supplement Containing Hydroxytyrosol and Punicalagin Improves Dyslipidemia in an Adult Population without Co-Adjuvant Treatment: A Randomized, Double-Blind, Controlled and Crossover Trial.口服含羟基酪醇和安石榴甙的补充剂可改善无辅助治疗的成年人群的血脂异常:一项随机、双盲、对照和交叉试验。
Nutrients. 2022 Apr 29;14(9):1879. doi: 10.3390/nu14091879.